Accendra Health (ACH) vs Cellyan Biotechnology (HKPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Accendra Health is the larger company by market cap ($34.1 million vs $5.0 million), about 6.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACH | HKPD |
|---|---|---|
| Share price | $0.4432 | $0.1008 |
| Market cap | $34.08M | $4.97M |
| 1-day change | -6.28% | -2.80% |
| YTD return | -84.17% | — |
| 1-year return | -90.61% | — |
| 5-year return | -98.65% | — |
| Forward P/E | 4.86 | — |
| EPS (TTM) | $-1.44 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.60 | $1.72 |
| 52-week low | $0.435 | $0.095 |
| Distance from 52-week high | -92.09% | -94.14% |
| Analyst consensus | hold | — |
| Avg. price target upside | +240.70% | — |
| Average volume | 1.41M | 3.78M |
| Shares outstanding | 76.90M | 42.17M |
| Employees | 6,500 | 11 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Accendra Health is about 6.9 times larger than Cellyan Biotechnology by market value ($34.08M vs $4.97M).
About Accendra Health
ACH stock →Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services.
Health Care · Medical Specialities · 6,500 employees
About Cellyan Biotechnology
HKPD stock →Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
Health Care · Other Pharmaceuticals · 11 employees
ACH vs HKPD FAQ
Which is bigger, Accendra Health or Cellyan Biotechnology?
Accendra Health (ACH) is larger, with a market capitalization of $34.08M compared with $4.97M for Cellyan Biotechnology (HKPD).
Are Accendra Health and Cellyan Biotechnology in the same industry?
Both are in the Health Care sector, but in different industries: Medical Specialities for Accendra Health and Other Pharmaceuticals for Cellyan Biotechnology.